Search results
Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based Booster
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and BioNTech (BNTX) complete submission of conditional marketing authorization to the...
Why Pfizer and BioNTech Stocks Zoomed Higher Today
Motley Fool· 8 months agoWhat happened Americans might not be as coronavirus-weary as some fear. Actually, these days they might be more coronavirus-wary. On the back of early...
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?
Investor's Business Daily· 2 years agoPfizer and BioNTech said Thursday they've started testing a next-generation Covid shot. But the...
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection
Benzinga via Yahoo Finance· 2 years agoPfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have initiated a Phase 1 study to evaluate the...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Resilience
GuruFocus.com via Yahoo Finance· 8 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac
Benzinga via Yahoo Finance· 2 years agoPfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have filed a complaint with the U.S. District...
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging...
Benzinga via Yahoo Finance· 2 years agoPfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced results from an analysis examining...
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Investor's Business Daily· 8 months agoModerna stock and BioNTech led a sell-off Monday among Covid vaccine makers after Pfizer slashed...
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
Benzinga via Yahoo Finance· 1 year agoA High Court battle between Pfizer Inc (NYSE: PFE), its partner BioNTech SE (NASDAQ: BNTX) locked in...
Pfizer/BioNTech Start Phase 2 Trial For COVID-19 Vaccine Against Omicron Subvariant
Benzinga via Yahoo Finance· 2 years agoPfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) initiated a randomized, active-controlled,...